Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Schrödinger, WuXi AppTec launch drug discovery JV

October 30, 2018 10:01 AM UTC

Computational physics company Schrödinger LLC (New York, N.Y.) and Shanghai-based R&D company WuXi AppTec Co. Ltd. (Shanghai:603259) created drug discovery JV Faxian Therapeutics (New York, N.Y.).

The JV will use Schrödinger's precision molecular design platforms to identify targets and indications with WuXi AppTec's small molecule design-synthesize-test cycle. Terms are not disclosed. Schrödinger declined to disclose ownership stakes and funding for Faxian...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article